Loading…
Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer
Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits...
Saved in:
Published in: | Cancer 2015-01, Vol.121 (2), p.202-213 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843 |
---|---|
cites | cdi_FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843 |
container_end_page | 213 |
container_issue | 2 |
container_start_page | 202 |
container_title | Cancer |
container_volume | 121 |
creator | Liu, Shujuan Zheng, Yong Volpi, Davide El‐Kasti, Muna Klotz, Daniel Tullis, Iain Henricks, Andrea Campo, Leticia Myers, Kevin Laios, Alex Thomas, Peter Ng, Tony Dhar, Sunanda Becker, Christian Vojnovic, Borivoj Ahmed, Ahmed Ashour |
description | Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits. |
doi_str_mv | 10.1002/cncr.29029 |
format | article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1002_cncr_29029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1002_cncr_29029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843</originalsourceid><addsrcrecordid>eNotkE1OwzAQhS0EEqWw4QReI6XYsZPUS1TxJxWx6YJdNBnbJah4IicElVWPwBk5CS50NXojvU96H2OXUsykEPk1Boyz3IjcHLGJFKbKhNT5MZsIIeZZodXLKTvr-7cUq7xQE7Zb0SdEy6lzEYZ2dLwNfGxH4n7zQdH16AKm5zus27Dm5Pnw6jj-7L75E3cD7yINlBIFpLULjnuKPLF6CrBpvxKSwqEVodvu6TRCbCFwhESO5-zEw6Z3F4c7Zau729XiIVs-3z8ubpYZVqXJJDTCegnWlAa89dZCY6xuNGpdaGxU40HCXIgCjSpLjyAlVhq9yVG5uVZTdvWPxUh9H52vu5hGxW0tRb1XV-_V1X_q1C_8SGfw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer</title><source>EZB Free E-Journals</source><source>Wiley-Blackwell Read & Publish Collection</source><creator>Liu, Shujuan ; Zheng, Yong ; Volpi, Davide ; El‐Kasti, Muna ; Klotz, Daniel ; Tullis, Iain ; Henricks, Andrea ; Campo, Leticia ; Myers, Kevin ; Laios, Alex ; Thomas, Peter ; Ng, Tony ; Dhar, Sunanda ; Becker, Christian ; Vojnovic, Borivoj ; Ahmed, Ahmed Ashour</creator><creatorcontrib>Liu, Shujuan ; Zheng, Yong ; Volpi, Davide ; El‐Kasti, Muna ; Klotz, Daniel ; Tullis, Iain ; Henricks, Andrea ; Campo, Leticia ; Myers, Kevin ; Laios, Alex ; Thomas, Peter ; Ng, Tony ; Dhar, Sunanda ; Becker, Christian ; Vojnovic, Borivoj ; Ahmed, Ahmed Ashour</creatorcontrib><description>Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.29029</identifier><language>eng</language><ispartof>Cancer, 2015-01, Vol.121 (2), p.202-213</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843</citedby><cites>FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Liu, Shujuan</creatorcontrib><creatorcontrib>Zheng, Yong</creatorcontrib><creatorcontrib>Volpi, Davide</creatorcontrib><creatorcontrib>El‐Kasti, Muna</creatorcontrib><creatorcontrib>Klotz, Daniel</creatorcontrib><creatorcontrib>Tullis, Iain</creatorcontrib><creatorcontrib>Henricks, Andrea</creatorcontrib><creatorcontrib>Campo, Leticia</creatorcontrib><creatorcontrib>Myers, Kevin</creatorcontrib><creatorcontrib>Laios, Alex</creatorcontrib><creatorcontrib>Thomas, Peter</creatorcontrib><creatorcontrib>Ng, Tony</creatorcontrib><creatorcontrib>Dhar, Sunanda</creatorcontrib><creatorcontrib>Becker, Christian</creatorcontrib><creatorcontrib>Vojnovic, Borivoj</creatorcontrib><creatorcontrib>Ahmed, Ahmed Ashour</creatorcontrib><title>Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer</title><title>Cancer</title><description>Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits.</description><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNotkE1OwzAQhS0EEqWw4QReI6XYsZPUS1TxJxWx6YJdNBnbJah4IicElVWPwBk5CS50NXojvU96H2OXUsykEPk1Boyz3IjcHLGJFKbKhNT5MZsIIeZZodXLKTvr-7cUq7xQE7Zb0SdEy6lzEYZ2dLwNfGxH4n7zQdH16AKm5zus27Dm5Pnw6jj-7L75E3cD7yINlBIFpLULjnuKPLF6CrBpvxKSwqEVodvu6TRCbCFwhESO5-zEw6Z3F4c7Zau729XiIVs-3z8ubpYZVqXJJDTCegnWlAa89dZCY6xuNGpdaGxU40HCXIgCjSpLjyAlVhq9yVG5uVZTdvWPxUh9H52vu5hGxW0tRb1XV-_V1X_q1C_8SGfw</recordid><startdate>20150115</startdate><enddate>20150115</enddate><creator>Liu, Shujuan</creator><creator>Zheng, Yong</creator><creator>Volpi, Davide</creator><creator>El‐Kasti, Muna</creator><creator>Klotz, Daniel</creator><creator>Tullis, Iain</creator><creator>Henricks, Andrea</creator><creator>Campo, Leticia</creator><creator>Myers, Kevin</creator><creator>Laios, Alex</creator><creator>Thomas, Peter</creator><creator>Ng, Tony</creator><creator>Dhar, Sunanda</creator><creator>Becker, Christian</creator><creator>Vojnovic, Borivoj</creator><creator>Ahmed, Ahmed Ashour</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20150115</creationdate><title>Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer</title><author>Liu, Shujuan ; Zheng, Yong ; Volpi, Davide ; El‐Kasti, Muna ; Klotz, Daniel ; Tullis, Iain ; Henricks, Andrea ; Campo, Leticia ; Myers, Kevin ; Laios, Alex ; Thomas, Peter ; Ng, Tony ; Dhar, Sunanda ; Becker, Christian ; Vojnovic, Borivoj ; Ahmed, Ahmed Ashour</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Shujuan</creatorcontrib><creatorcontrib>Zheng, Yong</creatorcontrib><creatorcontrib>Volpi, Davide</creatorcontrib><creatorcontrib>El‐Kasti, Muna</creatorcontrib><creatorcontrib>Klotz, Daniel</creatorcontrib><creatorcontrib>Tullis, Iain</creatorcontrib><creatorcontrib>Henricks, Andrea</creatorcontrib><creatorcontrib>Campo, Leticia</creatorcontrib><creatorcontrib>Myers, Kevin</creatorcontrib><creatorcontrib>Laios, Alex</creatorcontrib><creatorcontrib>Thomas, Peter</creatorcontrib><creatorcontrib>Ng, Tony</creatorcontrib><creatorcontrib>Dhar, Sunanda</creatorcontrib><creatorcontrib>Becker, Christian</creatorcontrib><creatorcontrib>Vojnovic, Borivoj</creatorcontrib><creatorcontrib>Ahmed, Ahmed Ashour</creatorcontrib><collection>CrossRef</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Shujuan</au><au>Zheng, Yong</au><au>Volpi, Davide</au><au>El‐Kasti, Muna</au><au>Klotz, Daniel</au><au>Tullis, Iain</au><au>Henricks, Andrea</au><au>Campo, Leticia</au><au>Myers, Kevin</au><au>Laios, Alex</au><au>Thomas, Peter</au><au>Ng, Tony</au><au>Dhar, Sunanda</au><au>Becker, Christian</au><au>Vojnovic, Borivoj</au><au>Ahmed, Ahmed Ashour</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer</atitle><jtitle>Cancer</jtitle><date>2015-01-15</date><risdate>2015</risdate><volume>121</volume><issue>2</issue><spage>202</spage><epage>213</epage><pages>202-213</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits.</abstract><doi>10.1002/cncr.29029</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2015-01, Vol.121 (2), p.202-213 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_crossref_primary_10_1002_cncr_29029 |
source | EZB Free E-Journals; Wiley-Blackwell Read & Publish Collection |
title | Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A02%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toward%20operative%20in%20vivo%20fluorescence%20imaging%20of%20the%20c%E2%80%90%20M%20et%20proto%E2%80%90oncogene%20for%20personalization%20of%20therapy%20in%20ovarian%20cancer&rft.jtitle=Cancer&rft.au=Liu,%20Shujuan&rft.date=2015-01-15&rft.volume=121&rft.issue=2&rft.spage=202&rft.epage=213&rft.pages=202-213&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.29029&rft_dat=%3Ccrossref%3E10_1002_cncr_29029%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c769-1ab0df1ad969afdfddab9d4b4c4454cb3bfa1a8005c9366fca11c74cf92c3e843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |